Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 73
2016 51
2017 48
2018 48
2019 46
2020 89
2021 137
2022 126
2023 87
2024 63

Text availability

Article attribute

Article type

Publication date

Search Results

741 results

Results by year

Filters applied: . Clear all
Page 1
Minimizing bleeding events.
Agewall S. Agewall S. Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):271-272. doi: 10.1093/ehjcvp/pvaa100. Eur Heart J Cardiovasc Pharmacother. 2020. PMID: 32932523 No abstract available.
Cardiovascular preventive actions.
Agewall S. Agewall S. Eur Heart J Cardiovasc Pharmacother. 2023 Sep 20;9(6):497-498. doi: 10.1093/ehjcvp/pvad054. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37727121 No abstract available.
Atrial fibrillation and stroke prevention.
Lewis BS. Lewis BS. Eur Heart J Cardiovasc Pharmacother. 2021 Apr 9;7(FI1):f1-f2. doi: 10.1093/ehjcvp/pvab023. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 33836529 No abstract available.
Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials.
Lombardi M, Carbone S, Del Buono MG, Chiabrando JG, Vescovo GM, Camilli M, Montone RA, Vergallo R, Abbate A, Biondi-Zoccai G, Dixon DL, Crea F. Lombardi M, et al. Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e69-e70. doi: 10.1093/ehjcvp/pvab008. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 33910233 Free PMC article. No abstract available.
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease.
Valgimigli M, Aboyans V, Angiolillo D, Atar D, Capodanno D, Halvorsen S, James S, Jüni P, Kunadian V, Landi A, Leonardi S, Mehran R, Montalescot G, Navarese EP, Niebauer J, Oliva A, Piccolo R, Price S, Storey RF, Völler H, Vranckx P, Windecker S, Fox KAA. Valgimigli M, et al. Eur Heart J Cardiovasc Pharmacother. 2023 Jul 29;9(5):462-496. doi: 10.1093/ehjcvp/pvad032. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37120728 Free article.
Optimizing individual heart failure treatment.
Agewall S. Agewall S. Eur Heart J Cardiovasc Pharmacother. 2022 Feb 16;8(2):105-107. doi: 10.1093/ehjcvp/pvab087. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35039827 No abstract available.
Antiplatelet treatment after PCI.
Agewall S. Agewall S. Eur Heart J Cardiovasc Pharmacother. 2023 Nov 2;9(7):593-594. doi: 10.1093/ehjcvp/pvad071. Eur Heart J Cardiovasc Pharmacother. 2023. PMID: 37846590 No abstract available.
741 results